Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 22 hours 29 min ago

FDA Eyes Site Tours of Cell and Gene Therapy Manufacturers

Tue, 07/16/2024 - 02:00

Democratic Senators to Meet with Novo Nordisk After Withdrawal of Levemir: Reuters

Tue, 07/16/2024 - 02:00

Vertex Sues US Government Over Fertility Services for Casgevy Treatment

Tue, 07/16/2024 - 02:00

Will Eli Lilly Overtake Novo Nordisk in Weight-Loss Drug Race?

Tue, 07/16/2024 - 02:00

Lexeo’s Gene Therapy Shows Early Promise for Friedreich’s Ataxia Cardiomyopathy

Mon, 07/15/2024 - 02:00

Metagenomi CSO Steps Down Shortly After IPO, Moderna Exit

Mon, 07/15/2024 - 02:00

Ozempic Tied to Lower Risk of Dementia, Nicotine Misuse: Study

Mon, 07/15/2024 - 02:00

Breaking the Cycle of Inflammation in Parkinson’s Disease

Mon, 07/15/2024 - 02:00

Congress Must Reauthorize FDA Program for Pediatric Rare Diseases

Mon, 07/15/2024 - 02:00

Breaking the Cycle of Inflammation in Parkinson’s Disease

Mon, 07/15/2024 - 02:00
Breaking the Cycle of Inflammation in Parkinson’s Disease 7/15/2024

5 Neuro Data Readouts to Watch in the Second Half of 2024

Mon, 07/15/2024 - 02:00
5 Neuro Data Readouts to Watch in the Second Half of 2024 7/15/2024

SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological

Mon, 07/15/2024 - 02:00
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological 7/15/2024

Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases

Mon, 07/15/2024 - 02:00
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases 7/15/2024

Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data

Sat, 07/06/2024 - 02:00
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data 6/7/2024

FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm

Sat, 07/06/2024 - 02:00
FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm 6/7/2024

FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder

Sat, 07/06/2024 - 02:00
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder 6/7/2024

Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate

Sat, 07/06/2024 - 02:00
Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate 6/7/2024

MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24

Sat, 07/06/2024 - 02:00
MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24 6/7/2024

AbbVie Sees Early ROI on $10B Immunogen Buy in Phase II Ovarian Cancer Win

Sat, 07/06/2024 - 02:00
AbbVie Sees Early ROI on $10B Immunogen Buy in Phase II Ovarian Cancer Win 6/7/2024

Vanda Gets $466M Unsolicited Offer from Cycle Amid Ongoing Row with FDA

Sat, 07/06/2024 - 02:00
Vanda Gets $466M Unsolicited Offer from Cycle Amid Ongoing Row with FDA 6/7/2024